IRIS
AMODIO, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.473
AS - Asia 3.163
EU - Europa 1.398
SA - Sud America 621
Continente sconosciuto - Info sul continente non disponibili 277
AF - Africa 57
OC - Oceania 6
Totale 9.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.341
SG - Singapore 1.526
CN - Cina 764
IT - Italia 681
BR - Brasile 484
VN - Vietnam 307
IN - India 277
SE - Svezia 202
GB - Regno Unito 132
DE - Germania 113
CA - Canada 87
HK - Hong Kong 76
AR - Argentina 51
FI - Finlandia 48
BD - Bangladesh 35
MX - Messico 29
RO - Romania 28
EC - Ecuador 26
IQ - Iraq 25
NL - Olanda 24
ID - Indonesia 23
RU - Federazione Russa 23
CL - Cile 22
PL - Polonia 22
UA - Ucraina 22
JP - Giappone 17
ES - Italia 16
FR - Francia 16
EU - Europa 15
CZ - Repubblica Ceca 13
EG - Egitto 13
PK - Pakistan 13
PY - Paraguay 13
TR - Turchia 13
ZA - Sudafrica 13
VE - Venezuela 11
JO - Giordania 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
IR - Iran 9
MY - Malesia 7
UZ - Uzbekistan 7
KE - Kenya 6
LT - Lituania 6
SA - Arabia Saudita 6
AU - Australia 5
CH - Svizzera 5
CO - Colombia 5
GR - Grecia 5
NP - Nepal 5
SC - Seychelles 5
YE - Yemen 5
DO - Repubblica Dominicana 4
EE - Estonia 4
HR - Croazia 4
IE - Irlanda 4
IL - Israele 4
MA - Marocco 4
MD - Moldavia 4
PH - Filippine 4
TN - Tunisia 4
UY - Uruguay 4
DZ - Algeria 3
KZ - Kazakistan 3
PA - Panama 3
PE - Perù 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
NO - Norvegia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NR - Nauru 1
Totale 9.729
Salva come PNG Salva come JPEG
Città #
San Jose 922
Singapore 508
Ashburn 388
Chandler 388
Santa Clara 264
Dallas 235
Hefei 225
Bengaluru 219
Council Bluffs 219
Milan 197
Lawrence 189
Princeton 189
Beijing 185
Catanzaro 139
Ho Chi Minh City 131
Wilmington 106
Chicago 91
London 90
Munich 84
Hong Kong 76
Hanoi 61
Des Moines 57
Los Angeles 47
Ottawa 47
São Paulo 47
Boardman 36
Turku 34
New York 26
Rio de Janeiro 26
Shanghai 24
Brooklyn 22
Haiphong 22
Redwood City 20
Rome 20
Phoenix 19
Warsaw 19
Guangzhou 16
San Francisco 16
Helsinki 14
Horia 14
Montreal 14
Pune 14
The Dalles 14
Da Nang 13
Naples 13
Norwalk 13
Olomouc 12
Stockholm 12
Baghdad 11
Bari 11
Boston 11
Hanover 10
Manchester 10
Mexico City 10
Redmond 10
Timisoara 10
Amman 9
Cosenza 9
Curitiba 9
Tokyo 9
Chennai 8
Columbus 8
Dhaka 8
Parma 8
Porto Alegre 8
Quito 8
Reggio Calabria 8
Santiago 8
Ann Arbor 7
Biên Hòa 7
Charlotte 7
Guayaquil 7
Jiaxing 7
Johannesburg 7
Lamezia Terme 7
Orem 7
Ovada 7
San Nicola Manfredi 7
Settingiano 7
Shenzhen 7
Tashkent 7
Amsterdam 6
Atlanta 6
Belo Horizonte 6
Frankfurt am Main 6
Nairobi 6
Palermo 6
Salvador 6
Thái Bình 6
Toronto 6
Uberlândia 6
West Jordan 6
Andover 5
Ankara 5
Augusta 5
Aversa 5
Campinas 5
Caracas 5
Caserta 5
Contagem 5
Totale 5.917
Salva come PNG Salva come JPEG
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 108
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 100
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 93
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro 88
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease 87
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 83
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 80
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 79
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 78
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS 77
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 75
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells 75
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 74
MiR-34a Replacement As a Novel Therapeutic Approach for Multiple Myeloma: Preclinical In Vitro and In Vivo Evidence 74
LNA-Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade 72
Early Hematopoietic Zinc Finger protein (EHZF), the human homologue to Evi3, is highly expressed in primitive human hematopoietic cells 72
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 71
Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches 70
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 70
Radiation induced by-stander effect: possible RNA implication in DNA damage transmission? 69
Molecular and clinical types of plasma cell dyscrasias are associated with distinct expression patterns of long noncoding RNAs 67
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 67
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 66
MIR-21 SUPPRESSION IMPAIRS TH17 RELATED BONE DISEASE IN MULTIPLE MYELOMA 66
Early hematopoietic zinc finger protein, a novel transcription co-factor with a potential role in haematopoietic homeostasis and leukaemogenesis 66
In Vitro Silencing of lncRNAs Using LNA GapmeRs 66
Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment 65
Impact of natural dietary agents on multiple myeloma prevention and treatment: molecular insights and potential for clinical translation. 65
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 65
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 65
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 65
ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer. 64
ACTIVATION OF GPER SIGNALING AS A POTENTIAL THERAPEUTIC STRATEGY AGAINST WALDENSTROM MACROGLOBULINEMIA 64
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 63
ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer 62
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 62
P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS 62
Contribution of PKB/AKT signaling to thyroid cancer 62
A 13 mer LNA miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells 61
Activation of the Non-Canonical Estrogen Receptor Gper As a Novel Therapeutic Strategy Against Waldenstrom Macroglobulinemia 61
Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction 61
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 60
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 59
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 59
Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation 59
MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment 59
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. 58
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides. 58
TARGETING OF DEREGULATED LNCRNA NEAT1 AFFECTS MULTIPLE MYELOMA ACTIVITY 58
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 58
Early hematopoietic zinc finger protein - zinc finger protein 521 (EHZF/ZNF521): a candidate regulator of diverse immature cells 58
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors 57
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma. 57
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 56
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 56
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma 56
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 56
Alternative non-homologous end joining DNA repair as therapeutic target in multiple myeloma 56
Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma 56
The non-coding RNA landscape of plasma cell dyscrasias 56
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 55
Selective Activation of the Non-Classical Estrogen Receptor Gper Elicits Potent Anti-Tumor Activity in Multiple Myeloma 55
Znf521 enhances mll‐af9‐dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape† 54
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 53
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 53
Non-coding RNA: A novel opportunity for the personalized treatment of multiple myeloma 53
Activating E17K mutation in the gene encoding the protein kinase B/AKT in squamous cell carcinoma of the lung 53
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 53
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 53
Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells 53
ZINC FINGER PROTEIN 521 (EHZF/ZNF521) ANTAGONIZES EARLY B-CELL FACTOR 1 AND MODULATES THE B-LYMPHOID DIFFERENTIATION OF PRIMARY HEMATOPOIETIC PROGENITORS 52
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. 51
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity 51
Biological Insights into Myeloma and Other B Cell Malignancies 51
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence 50
Synthetic MiR-29b Mimics Potentiate Dendritic-Cell Based Immunotherapy Against Multiple Myeloma In Vitro and In Vivo 50
Arginine Methylation Mediated By PRMT5 Has Significant Biological and Clinical Impact in Multiple Myeloma 50
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 49
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies 49
Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection 49
Protective role of GPER agonist g-1 on cardiotoxicity induced by doxorubicin 49
miR-22 suppresses DNA ligase III addiction in multiple myeloma. 49
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 49
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma 48
Inhibition Of Mir-21 In HS-5 Bone Marrow Stromal Cells In The Presence Of Multiple Myeloma cells Restores RANKL/OPG Ratio: A Potential Therapeutic Approach For Myeloma-Related Bone Disease 48
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart 48
Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment. 48
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 48
Contribution of PKB/AKT signaling to thyroid cancer 47
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 47
Tumor Suppressor MiR-29b Targets HDAC4 and Modulates Vorinostat Activity In Multiple Myeloma Cells 47
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation 46
In vitro and vivo activity against multiple myeloma cells of a novel locked nucleic acid (LNA)-miR-221 inhibitor 46
Early Hematopoietic Zinc Finger (EHZF/ZNF521) prevents tumor cell recognition by Natural Killer Cells 46
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 45
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario 45
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma 45
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 45
Expression pattern and biological significance of the lncRNA ST3GAL6-AS1 in multiple myeloma 45
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 44
Totale 6.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022546 0 2 5 154 38 13 24 113 54 61 71 11
2022/20231.183 386 64 71 68 100 93 5 87 163 51 70 25
2023/2024515 113 73 34 42 28 129 13 8 2 14 19 40
2024/20252.129 321 95 65 58 151 302 44 51 266 130 214 432
2025/20264.686 264 494 445 773 518 181 604 275 639 324 132 37
2026/2027333 67 266 0 0 0 0 0 0 0 0 0 0
Totale 9.995